David A. Socks

VP, CADENCE PHARMACEUTICALS INC.

Companies

Phathom Pharmaceuticals, Inc.Board member Oct 24, 2019 to May 24, 2024¹
HilleVax, Inc.Chief financial officer Apr 28, 2022 to Apr 28, 2022²
Phathom Pharmaceuticals, Inc.Chief executive officer Oct 24, 2019 to Oct 24, 2019¹
Phathom Pharmaceuticals, Inc.President Oct 24, 2019 to Oct 24, 2019¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Phathom Pharmaceuticals, Inc. PHAT19,910 shares³$139.9K at $7.03May 24, 2024
HilleVax, Inc.769,055 shares⁴Apr 28, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 23, 2024Granted 10,500 shares of Phathom Pharmaceuticals, Inc.³
May 25, 2023Granted 9,000 shares of Phathom Pharmaceuticals, Inc.⁵
Oct 8, 2021Sold 2,529 shares at $32.05 of Phathom Pharmaceuticals, Inc.⁶
Oct 7, 2021Sold 15,471 shares at $32.66 of Phathom Pharmaceuticals, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPhathom Pharmaceuticals, Inc., Board member
2
SEC EDGARHilleVax, Inc., Chief financial officer
3
SEC EDGARPhathom Pharmaceuticals, Inc. shares after the filing of May 24, 2024
4
SEC EDGARHilleVax, Inc. shares after the filing of Apr 28, 2022
5
SEC EDGARForm 4 filed May 30, 2023
6
SEC EDGARForm 4 filed Oct 8, 2021